Ads
related to: nvcr stock
Search results
NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 month agoNovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The...
Wall Street Analysts Predict a 105.85% Upside in NovoCure (NVCR): Here's What You Should Know
Zacks via Yahoo Finance· 4 months agoThe mean of analysts' price targets for NovoCure (NVCR) points to a 105.9% upside in the stock....
NovoCure (NVCR): A Smart Investment or a Value Trap? An In-Depth Exploration
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
NovoCure (NASDAQ:NVCR investor three-year losses grow to 90% as the stock sheds US$229m this past...
Simply Wall St. via Yahoo Finance· 7 months agoAs every investor would know, not every swing hits the sweet spot. But you have a problem if you...
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNovoCure (NVCR) delivered earnings and revenue surprises of -64.29% and 4.39%, respectively, for the...
NovoCure Limited (NASDAQ:NVCR) institutional owners may be pleased with recent gains after 85% loss...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Given the large stake in the stock by institutions, NovoCure's stock price might be...
Is NovoCure Limited (NASDAQ:NVCR) Worth US$16.0 Based On Its Intrinsic Value?
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights NovoCure's estimated fair value is US$12.01 based on 2 Stage Free Cash Flow to Equity...
Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes
Investor's Business Daily· 1 year agoNovocure announced a series of C-suite changes on Thursday as investor debate continues to haunt its...
After losing 33% in the past year, NovoCure Limited (NASDAQ:NVCR) institutional owners must be...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls NovoCure Limited (NASDAQ:NVCR), then you'll have to look at...
Novocure Plummets 38% After Its Treatment For Ovarian Cancer Fails
Investor's Business Daily· 8 months agoNovocure said Monday its electrical-based cancer treatment failed to make a difference for ovarian...
